霍奇金淋巴瘤长期幸存者中与慢性疾病相关的神经认知功能损害
本研究纳入204例接受过胸部放疗的霍奇金淋巴瘤长期幸存者和205名匹配对照,同期完成神经认知测试及心、肺、血管检查。幸存者视运动、视觉处理速度、短期回忆和灵活性表现低于对照,且肺功能、心脏功能及血管功能也较低,这些亚临床异常与神经认知表现相关,提示预防健康损害可能有益于神经认知结局。
要点
- 幸存者视运动(0.11 vs 0.41)、视觉处理速度(0.25 vs 0.64)、短期回忆(-0.24 vs 0.12)和灵活性(-0.04 vs 0.28)表现低于对照(P < 0.05)。
- 幸存者FEV1、DLCOcorr、LVEF、GLS和SAE均低于对照(均P < 0.001)。
- FEV1与视运动和视觉处理速度及灵活性相关,GLS与短期回忆相关,SAE与灵活性相关,神经认知结局还与中重度神经系统慢性疾病相关(P < .05)。
核心结论
- 研究结果提示亚临床心肺和血管发现、神经系统疾病与神经认知功能损害之间存在关联,预防健康损害可能有益于神经认知结局。
研究设计与样本
- 研究纳入204例接受胸部放疗的霍奇金淋巴瘤长期幸存者(52.5%女性,平均年龄36.6岁,标准差8.01)和205名按年龄、性别、种族/民族匹配的社区对照(51.7%女性,平均年龄36.7岁,标准差9.17)。
- 幸存者和对照在同一访视中完成标准化神经认知测试、超声心动图、肺功能检查和血管检查,治疗信息从医疗记录中提取。
- 采用多变量线性回归评估心脏(LVEF、GLS)、血管(大动脉和小动脉弹性[SAE])、肺(DLCO和FEV1)及慢性健康状况与年龄校正神经认知表现之间的关联。
主要发现
- 与对照相比,幸存者视运动表现较低(0.11 vs 0.41,P < 0.05)、视觉处理速度较低(0.25 vs 0.64,P < 0.05)、短期回忆较低(-0.24 vs 0.12,P < 0.05)、灵活性较低(-0.04 vs 0.28,P < 0.05)。
- 幸存者肺功能(FEV1、DLCOcorr)、心脏功能(LVEF、GLS)和血管功能(SAE)均低于对照(均P < 0.001)。
- FEV1与视运动(P = .008)、视觉处理速度(P = .05)和灵活性(P = .05)相关;GLS与短期回忆相关(P = .03);SAE与灵活性相关(P = .007)。
- 神经认知结局还与中重度神经系统慢性疾病相关(P < .05)。
关键数值与推荐
- 幸存者视运动表现0.11 vs 对照0.41(P < 0.05)。
- 幸存者视觉处理速度0.25 vs 对照0.64(P < 0.05)。
- 幸存者短期回忆-0.24 vs 对照0.12(P < 0.05)。
- 幸存者灵活性-0.04 vs 对照0.28(P < 0.05)。
- 幸存者FEV1、DLCOcorr、LVEF、GLS和SAE均低于对照(均P < 0.001)。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Thoracic radiation is associated with significant cardiopulmonary morbidities in survivors of long-term Hodgkin lymphoma and may affect neurocognitive outcomes. Survivors (N = 204; 52.5% female; mean [standard deviation] age, 36.6 [8.01] years) treated with thoracic radiation and age-, sex-, and race/ethnicity-matched community controls (N = 205; 51.7% female; age, 36.7 [9.17] years) completed standardized neurocognitive testing, echocardiography, pulmonary function tests, and vascular studies during the same visit. Treatments were abstracted from medical records. Cardiac (ie, left ventricular ejection fraction [LVEF], global longitudinal strain [GLS]), vascular (ie, large and small artery elasticity [SAE]), pulmonary (ie, diffusing capacity of the lungs for carbon monoxide [DLCO] and forced expiratory volume [FEV1]), and chronic health conditions were evaluated for associations with age-adjusted neurocognitive performance using multivariable linear regression. Compared with controls, survivors had lower performance (P < 0.05) in visuomotor (0.11 vs 0.41), visual processing speed (0.25 vs 0.64), short-term recall (-0.24 vs 0.12), and flexibility (-0.04 vs 0.28). Survivors had lower pulmonary (FEV1, DLCOcorr), cardiac (LVEF, GLS), and vascular function (SAE) than controls (all P < 0.001). FEV1 was associated with visuomotor (P = .008) and visual processing speed (P = .05), and flexibility (P = .05). GLS was associated with short-term recall (P = .03). SAE was associated with flexibility (P = .007). Neurocognitive outcomes were also associated with moderate-to-severe neurologic chronic conditions (P < .05). Findings suggest a link between subclinical cardiopulmonary and vascular findings, neurologic morbidity, and neurocognitive impairments. Prevention of health morbidity may benefit neurocognitive outcomes.
引用
- Phillips NS, Mulrooney DA, Williams AM, et al. Neurocognitive impairment associated with chronic morbidity in long-term survivors of Hodgkin Lymphoma. Blood Adv. 2023. PMID: 37729618. doi:10.1182/bloodadvances.2023010567
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。